Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Dis...

FDA Drug Recall #D-0171-2025 — Class II — December 10, 2024

Recall Summary

Recall Number D-0171-2025
Classification Class II — Moderate risk
Date Initiated December 10, 2024
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm VIONA PHARMACEUTICALS INC
Location Cranford, NJ
Product Type Drugs
Quantity 23304 packs

Product Description

Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

Reason for Recall

Crystallization

Distribution Pattern

US Nationwide

Lot / Code Information

Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.

Other Recalls from VIONA PHARMACEUTICALS INC

Recall # Classification Product Date
D-0016-2026 Class II Tavaborole Topical solution 5%, 10 mL bottle, R... Oct 6, 2025
D-0595-2025 Class II Tavaborole Topical Solution 5%, 10 mL per glass... Aug 12, 2025
D-0172-2025 Class II Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured b... Dec 10, 2024
D-0038-2025 Class II Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufa... Oct 29, 2024
D-0011-2025 Class II Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufa... Sep 24, 2024

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.